Results 91 to 100 of about 14,994 (162)

Increasing day three parasitaemia is observed after treatment of patients with artemether-lumefantrine and single dose of primaquine for uncomplicated Plasmodium falciparum malaria in Arbaminch Zuria district, Southwest Ethiopia. [PDF]

Malar J
Abate B, Brhane BG, Manyazewal T, Mohammed H, Wuletaw Y, Kassa M, Hailu M, Tollera G, Tasew G, Assefa A, Makonnen E.   +10 more
europepmc   +1 more source

Splenic infarction in a paediatric patient with Plasmodium vivax malaria from Ethiopia: a case report. [PDF]

Malar J
Tekle AB, Bekele TT, Solbamo AB, Kebede MA, Berhanu MT, Baramo DD.   +5 more
europepmc   +1 more source

Chloroquine-primaquine therapeutic response and safety in patients with uncomplicated Plasmodium vivax malaria in the Colombian Amazon region. [PDF]

Malar J
Calderón-Ruiz P, Velez-Tobón G, Bolívar-Hernández S, Murcia-Montaño LM, Tobón-Castaño A.   +4 more
europepmc   +1 more source

Clinical characteristics of Plasmodium vivax malaria infection in children and adolescents in the Republic of Korea during the period 2000 to 2016: a retrospective study. [PDF]

BMC Infect Dis
Lee JA, Song JE, Park SY, Park YS, Park Y, Kwak YG, Lee SE, Shin HI, Yeom JS.   +8 more
europepmc   +1 more source

Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax ? [PDF]

Malar J
White NJ, Mehra S, Watson JA.
europepmc   +1 more source

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure. [PDF]

Malar J
Abla N, Marrast AC, Jambert E, Richardson N, Duparc S, Almond L, Rowland Yeo K, Pan X, Tarning J, Zhao P, Culpepper J, Waitt C, Koldeweij C, Cole S, Butler AS, Khier S, Möhrle JJ, El Gaaloul M.   +17 more
europepmc   +1 more source

Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis. [PDF]

Lancet Child Adolesc Health
Commons RJ, Rajasekhar M, Allen EN, Yilma D, Chotsiri P, Abreha T, Adam I, Awab GR, Barber BE, Brasil LW, Chu CS, Cui L, Edler P, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Hamid MMA, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Longley RJ, Monteiro WM, Pasaribu AP, Poespoprodjo JR, Richmond CL, Rijal KR, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Zuluaga-Idarraga LM, Workman LJ, Tarning J, Stepniewska K, Guerin PJ, Simpson JA, Barnes KI, Price RN, WorldWide Antimalarial Resistance Network Paediatric Primaquine Vivax Study Group.   +41 more
europepmc   +1 more source

Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial.

Lancet Microbe
Mahamar A, Vanheer LN, Smit MJ, Sanogo K, Sinaba Y, Niambele SM, Diallo M, Dicko OM, Diarra RS, Maguiraga SO, Youssouf A, Sacko A, Keita S, Samake S, Dembele A, Teelen K, Dicko Y, Traore SF, Dondorp A, Drakeley C, Stone W, Dicko A.   +21 more
europepmc   +1 more source

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis. [PDF]

PLoS Med
Fadilah I, Commons RJ, Chau NH, Chu CS, Day NPJ, Koh GCKW, Green JA, Lacerda MV, Llanos-Cuentas A, Nelwan EJ, Nosten F, Pasaribu AP, Sutanto I, Taylor WRJ, Thriemer K, Price RN, White NJ, Baird JK, Watson JA.   +18 more
europepmc   +1 more source

[Effect of low-dose primaquine treatment on Plasmodium vivax recurrence and transmission-blocking activity in southwest Ethiopia: a longitudinal cohort study. [PDF]

Malar J
Getachew H, Habtamu K, Abossie A, Demissew A, Tsegaye A, Degefa T, Zhong D, Wang X, Zhou G, Lee M, Kazura JW, King CL, Yewhalaw D, Yan G.   +13 more
europepmc   +1 more source